NASDAQ:HGSI - Human Genome Sciences Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Human Genome Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Human Genome Sciences, Inc (HGS) is a biopharmaceutical company. The Company's products include BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. HGS continues to deliver raxibacumab to the United States Strategic National Stockpile (SNS) for emergency use in treating inhalation anthrax. In addition to the Company's internal pipeline, it has financial rights to two drugs that GlaxoSmithKline (GSK) has advanced to late-stage development. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:HGSI Previous Symbol CUSIPN/A CIK901219 Webhttp://www.hgsi.com/ Phone+1-301-3098504Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive HGSI News and Ratings via Email Sign-up to receive the latest news and ratings for HGSI and its competitors with MarketBeat's FREE daily newsletter. Human Genome Sciences (NASDAQ:HGSI) Frequently Asked Questions What is Human Genome Sciences' stock symbol? Human Genome Sciences trades on the NASDAQ under the ticker symbol "HGSI." Has Human Genome Sciences been receiving favorable news coverage? Media headlines about HGSI stock have trended somewhat positive this week, InfoTrie reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Human Genome Sciences earned a news impact score of 1.2 on InfoTrie's scale. They also assigned headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Human Genome Sciences. What other stocks do shareholders of Human Genome Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Human Genome Sciences investors own include Bank of America (BAC), Jazz Pharmaceuticals (JAZZ), InterMune (ITMN), Intel (INTC), Alphabet (GOOG), First Solar (FSLR), Finisar (FNSR), Changyou.Com (CYOU), Cisco Systems (CSCO) and Advanced Micro Devices (AMD). What is Human Genome Sciences' official website? The official website for Human Genome Sciences is http://www.hgsi.com/. How can I contact Human Genome Sciences? Human Genome Sciences' mailing address is 14200 Shady Grove Rd, ROCKVILLE, MD 20850-7464, United States. The biopharmaceutical company can be reached via phone at +1-301-3098504. MarketBeat Community Rating for Human Genome Sciences (NASDAQ HGSI)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 131 (Vote Outperform)Underperform Votes: 145 (Vote Underperform)Total Votes: 276MarketBeat's community ratings are surveys of what our community members think about Human Genome Sciences and other stocks. Vote "Outperform" if you believe HGSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HGSI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/10/2019 by MarketBeat.com StaffFeatured Article: What is Blockchain?